4 unchanged sentences
Amended and Restated Bylaws of Atara Biotherapeutics, Inc.
−Removed: Research, Development and License Agreement, by and between Atara Biotherapeutics, Inc.
−Removed: and Bayer AG, dated December 4, 2020
−Removed: Lease Agreement between LA Region No.
−Removed: 2, LLC and Atara Biotherapeutics, Inc.
−Removed: dated March 17, 2021
−Removed: First Amended and Restated Exclusive License Agreement by and between Atara Biotherapeutics, Inc.
−Removed: and Memorial Sloan Kettering Cancer Center, dated March 22, 2021
+Added: Deed of Amendment Number 1 to Third Amended and Restated License Agreement dated April 21, 2021
Certification by Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
7 unchanged sentences
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
−Removed: The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, formatted in Inline XBRL.
+Added: The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, formatted in Inline XBRL.
Portions of this exhibit have been omitted as being both (i) not material and (ii) the type of information that the registrant treats as private or confidential.
−Removed: Previously filed with Annual Report on Form 10-K on March 1, 2021;
−Removed: refiled here with corrected formatting.
The certifications attached as Exhibit 32.1 accompany this Quarterly Report on Form 10-Q pursuant to 18 U.S.C.
3 unchanged sentences
ATARA BIOTHERAPEUTICS, INC.
+Added: August 9, 2021
/s/ Pascal Touchon
9 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.